---
url: https://www.servicesaustralia.gov.au/fibrodysplasia-ossificans-progressiva
title: Fibrodysplasia ossificans progressiva - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:40:36.209Z
source: servicesaustralia.gov.au
---
# Fibrodysplasia ossificans progressiva

The PBS subsidises palovarotene for patients with fibrodysplasia ossificans progressiva (FOP).

## on this page

-   [Patient eligibility](#a1)
-   [Treatment specifics](#a2)
-   [Authority applications](#a3)
-   [More information](#a4)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with palovarotene under the _National Health Act 1953_, section 85 for patients with FOP.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing palovarotene.

## Treatment specifics

To be eligible for PBS-subsidised treatment with palovarotene, patients must be treated by, or in consultation with, a specialist medical practitioner experienced in the diagnosis and management of FOP.

## Authority applications

### Applying for chronic treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for authority approval to prescribe PBS-subsidised palovarotene for chronic treatment of FOP can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and use [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mail to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [fibrodysplasia ossificans progressiva - palovarotene - chronic treatment authority application form](/pb387?context=20)
-   relevant attachments.

### Applying for flare-up (acute) treatment

Flare-up (acute) treatment of FOP with PBS-subsidised palovarotene is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.
